Aclaris Therapeutics logo

Aclaris Therapeutics share price today

(ACRS)

Aclaris Therapeutics share price is $2.53 & ₹217.10 as on 7 Jan 2025, 2.30 'hrs' IST

$2.53

-0.07

(-2.69%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Aclaris Therapeutics share price in Dollar and Rupees. Guide to invest in Aclaris Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aclaris Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Aclaris Therapeutics share price movements

  • Today's Low: $2.45
    Today's High: $2.65

    Day's Volatility :7.37%

  • 52 Weeks Low: $0.86
    52 Weeks High: $5.17

    52 Weeks Volatility :83.45%

Aclaris Therapeutics Returns

PeriodAclaris Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
124.14%
-8.4%
0.0%
6 Months
106.35%
-3.8%
0.0%
1 Year
120.34%
-0.1%
0.0%
3 Years
-79.12%
2.9%
-19.8%

Aclaris Therapeutics Key Statistics

in dollars & INR

Previous Close
$2.6
Open
$2.63
Today's High
$2.645
Today's Low
$2.45
Market Capitalization
$265.4M
Today's Volume
$1.0M
52 Week High
$5.17
52 Week Low
$0.8555
Revenue TTM
$27.1M
EBITDA
$-62.2M
Earnings Per Share (EPS)
$-0.52
Profit Margin
-136.65%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-25.83%

How to invest in Aclaris Therapeutics from India?

It is very easy for Indian residents to invest directly in Aclaris Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aclaris Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aclaris Therapeutics or ACRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aclaris Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aclaris Therapeutics shares which would translate to 0.339 fractional shares of Aclaris Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aclaris Therapeutics, in just a few clicks!

Returns in Aclaris Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aclaris Therapeutics investment value today

Current value as on today

₹2,17,629

Returns

₹1,17,629

(+117.63%)

Returns from Aclaris Therapeutics Stock

₹1,14,407 (+114.41%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Aclaris Therapeutics

-62%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Aclaris Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -62% less investors are searching Aclaris Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Aclaris Therapeutics

  • BML Capital Management LLC

    13.32%

  • Vanguard Group Inc

    4.38%

  • D. E. Shaw & Co LP

    3.15%

  • Millennium Management LLC

    2.81%

  • Rock Springs Capital Management LP

    2.57%

  • Stonepine Capital Management Llc

    2.30%

Analyst Recommendation on Aclaris Therapeutics

Hold

    40%Buy

    60%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Aclaris Therapeutics(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
9
9
9
Sell
0
0
0

Analyst Forecast on Aclaris Therapeutics

What analysts predicted

Upside of 295.26%

Current:

$2.53

Target:

$10.00

Insights on Aclaris Therapeutics

  • Price Movement

    In the last 1 month, ACRS stock has moved down by -34.0%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 2.39M → 4.34M (in $), with an average increase of 24.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -16.94M → -7.58M (in $), with an average increase of 49.5% per quarter
  • ACRS vs A (3 yr)

    In the last 3 years, Aclaris Therapeutics Inc has experienced a drawdown of -80.2%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 71.2%

Aclaris Therapeutics Financials in INR & Dollars

FY18Y/Y Change
Revenue
$10.1M
↑ 499.58%
Net Income
$-132.7M
↑ 93.71%
Net Profit Margin
-1.3K%
↑ 2756.07%
FY19Y/Y Change
Revenue
$4.2M
↓ 58.11%
Net Income
$-142.9M
↑ 7.62%
Net Profit Margin
-3.4K%
↓ 2064.06%
FY20Y/Y Change
Revenue
$6.5M
↑ 53.35%
Net Income
$-51.2M
↓ 64.19%
Net Profit Margin
-789.17%
↑ 2590.3%
FY21Y/Y Change
Revenue
$6.8M
↑ 4.3%
Net Income
$-114.3M
↑ 123.41%
Net Profit Margin
-1.7K%
↓ 901.13%
FY22Y/Y Change
Revenue
$29.8M
↑ 340.05%
Net Income
$-88.7M
↓ 22.42%
Net Profit Margin
-298.0%
↑ 1392.3%
FY23Y/Y Change
Revenue
$31.2M
↑ 5.03%
Net Income
$-88.5M
↓ 0.2%
Net Profit Margin
-283.15%
↑ 14.85%
Q2 FY23Q/Q Change
Revenue
$1.9M
↓ 26.07%
Net Income
$-29.6M
↑ 12.0%
Net Profit Margin
-1.6K%
↓ 537.7%
Q3 FY23Q/Q Change
Revenue
$9.3M
↑ 396.63%
Net Income
$-29.3M
↓ 1.04%
Net Profit Margin
-315.24%
↑ 1266.84%
Q4 FY23Q/Q Change
Revenue
$17.6M
↑ 89.29%
Net Income
$-1.5M
↓ 94.9%
Net Profit Margin
-8.49%
↑ 306.75%
Q1 FY24Q/Q Change
Revenue
$2.4M
↓ 86.35%
Net Income
$-16.9M
↑ 1036.22%
Net Profit Margin
-706.46%
↓ 697.97%
Q2 FY24Q/Q Change
Revenue
$2.8M
↑ 15.35%
Net Income
$-11.0M
↓ 35.15%
Net Profit Margin
-397.18%
↑ 309.28%
Q3 FY24Q/Q Change
Revenue
$4.3M
↑ 57.12%
Net Income
$-7.6M
↓ 30.95%
Net Profit Margin
-174.55%
↑ 222.63%
FY18Y/Y Change
Profit
$3.2M
↑ 580.88%
FY19Y/Y Change
Profit
$172.0K
↓ 94.69%
FY20Y/Y Change
Profit
$1.3M
↑ 684.3%
FY21Y/Y Change
Profit
$2.0M
↑ 51.82%
FY22Y/Y Change
Profit
$17.8M
↑ 768.75%
FY23Y/Y Change
Profit
$13.2M
↓ 25.99%
Q2 FY23Q/Q Change
Profit
$277.0K
↓ 57.97%
Q3 FY23Q/Q Change
Profit
$8.4M
↑ 2944.77%
Q4 FY23Q/Q Change
Profit
$11.1M
↑ 32.11%
Q1 FY24Q/Q Change
Profit
$558.0K
↓ 94.99%
Q2 FY24Q/Q Change
Profit
$857.0K
↑ 53.58%
Q3 FY24Q/Q Change
Profit
$1.9M
↑ 126.14%
FY18Y/Y Change
Operating Cash Flow
$-100.8M
↑ 84.42%
Investing Cash Flow
$9.4M
↓ 116.82%
Financing Cash Flow
$128.3M
↑ 27.77%
FY19Y/Y Change
Operating Cash Flow
$-96.4M
↓ 4.33%
Investing Cash Flow
$105.7M
↑ 1028.21%
Financing Cash Flow
$-30.3M
↓ 123.64%
FY20Y/Y Change
Operating Cash Flow
$-38.6M
↓ 59.94%
Investing Cash Flow
$6.4M
↓ 93.96%
Financing Cash Flow
$18.4M
↓ 160.6%
FY21Y/Y Change
Operating Cash Flow
$-52.1M
↑ 34.95%
Investing Cash Flow
$-167.6M
↓ 2724.58%
Financing Cash Flow
$225.1M
↑ 1124.97%
FY22Y/Y Change
Operating Cash Flow
$-67.6M
↑ 29.6%
Investing Cash Flow
$12.6M
↓ 107.53%
Financing Cash Flow
$72.9M
↓ 67.62%
Q2 FY23Q/Q Change
Operating Cash Flow
$-20.7M
↓ 21.63%
Investing Cash Flow
$-19.7M
↓ 176.22%
Financing Cash Flow
$26.7M
↑ 0.0%
Q3 FY23Q/Q Change
Operating Cash Flow
$-24.6M
↑ 18.9%
Investing Cash Flow
$32.5M
↓ 265.47%
Financing Cash Flow
$-87.0K
↓ 100.33%

Aclaris Therapeutics Technicals Summary

Sell

Neutral

Buy

Aclaris Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aclaris Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aclaris Therapeutics Inc
-33.5%
106.35%
120.34%
-79.12%
39.78%
Idexx Laboratories, Inc.
-7.8%
-13.05%
-23.61%
-25.62%
49.5%
Agilent Technologies Inc.
-5.77%
8.19%
1.73%
-6.52%
55.48%
Thermo Fisher Scientific, Inc.
-0.97%
0.03%
-1.73%
-14.88%
61.41%
Danaher Corp.
-0.45%
-2.06%
-0.01%
-22.5%
48.94%
Iqvia Holdings Inc.
-4.38%
-7.35%
-11.9%
-23.26%
23.76%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aclaris Therapeutics Inc
NA
NA
-0.13
-0.86
-0.26
-0.19
NA
1.82
Idexx Laboratories, Inc.
39.83
39.83
4.35
10.73
0.59
0.23
NA
19.72
Agilent Technologies Inc.
30.63
30.63
2.26
5.56
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
32.58
32.58
1.98
21.7
0.13
0.05
0.0
128.08
Danaher Corp.
43.31
43.31
3.07
7.5
0.08
0.04
0.0
71.03
Iqvia Holdings Inc.
25.94
25.94
1.03
11.11
0.22
0.05
NA
38.37
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aclaris Therapeutics Inc
Hold
$265.4M
39.78%
NA
-136.65%
Idexx Laboratories, Inc.
Buy
$33.9B
49.5%
39.83
22.53%
Agilent Technologies Inc.
Buy
$38.8B
55.48%
30.63
21.75%
Thermo Fisher Scientific, Inc.
Buy
$199.0B
61.41%
32.58
14.48%
Danaher Corp.
Buy
$165.8B
48.94%
43.31
16.39%
Iqvia Holdings Inc.
Buy
$35.8B
23.76%
25.94
9.17%

About Aclaris Therapeutics

aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.
Organization
Aclaris Therapeutics
Employees
86
CEO
Dr. Neal S. Walker D.O., M.D.
Industry
Health Technology

Management People of Aclaris Therapeutics

NameTitle
Dr. Neal S. Walker D.O., M.D.
Co-Founder, Interim CEO & Chairman
Mr. Kevin Balthaser
Chief Financial Officer
Dr. Joseph Monahan Ph.D.
Chief Scientific Officer
Mr. James Loerop
Chief Business Officer
Dr. Hugh M. Davis Ph.D.
President, COO & Director
Mr. Matthew Rothman J.D.
General Counsel & Corporate Secretary
Dr. Jon Jacobsen Ph.D.
Senior Vice President of Chemistry
Mr. Steve Tucker
Senior Vice President of Project Leadership
Mr. Ajay Aggarwal M.B.A., M.D.
Senior Vice President of Clinical Development
Dr. Steven Knapp M.S. Pharm.D.
Executive Vice President, Regulatory Affairs & Quality Assurance

Important FAQs about investing in Aclaris Therapeutics from India :

What is Aclaris Therapeutics share price today?

Aclaris Therapeutics share price today stands at $2.53, Open: $2.63 ; Previous Close: $2.60 ; High: $2.65 ; Low: $2.45 ; 52 Week High: $5.17 ; 52 Week Low: $0.86. The stock opens at $2.63, after a previous close of $2.60. The stock reached a daily high of $2.65 and a low of $2.45, with a 52-week high of $5.17 and a 52-week low of $0.86.

Can Indians buy Aclaris Therapeutics shares?

Yes, Indians can invest in the Aclaris Therapeutics (ACRS) from India.

With INDmoney, you can buy Aclaris Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aclaris Therapeutics at zero transaction cost.

How can I buy Aclaris Therapeutics shares from India?

It is very easy to buy Aclaris Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aclaris Therapeutics be purchased?

Yes, you can buy fractional shares of Aclaris Therapeutics with INDmoney app.

What are the documents required to start investing in Aclaris Therapeutics stocks?

To start investing in Aclaris Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aclaris Therapeutics

Today’s highest price of Aclaris Therapeutics (ACRS) is $2.65.

Today’s lowest price of Aclaris Therapeutics (ACRS) is $2.45.

What is today's market capitalisation of Aclaris Therapeutics

Today's market capitalisation of Aclaris Therapeutics ACRS is 265.4M

What is the 52 Week High and Low Range of Aclaris Therapeutics

  • 52 Week High

    $5.17

  • 52 Week Low

    $0.86

What are the historical returns of Aclaris Therapeutics?

  • 1 Month Returns

    -33.5%

  • 3 Months Returns

    106.35%

  • 1 Year Returns

    120.34%

  • 5 Years Returns

    39.78%

Who is the Chief Executive Officer (CEO) of Aclaris Therapeutics

Dr. Neal S. Walker D.O., M.D. is the current Chief Executive Officer (CEO) of Aclaris Therapeutics.